The Filing Desk

Neuroone Medical Technologies vs InspireMD

Neuroone Medical Technologies NMTC · InspireMD NSPR · Health Care Equipment

Neuroone Medical Technologies reported revenue of $9 million in fiscal 2025, about the same as InspireMD's $9 million in fiscal 2025. Neuroone Medical Technologies' revenue grew 163.5% in its latest year, and InspireMD's grew 28.1%. Neuroone Medical Technologies had an operating margin of -46.5%, against -552.6% at InspireMD. Free cash flow was −$3 million at Neuroone Medical Technologies and −$37 million at InspireMD. Their fiscal years end in different months (September 30 and December 31), so the periods don't line up exactly.

Side by side

Neuroone Medical TechnologiesInspireMD
Latest fiscal yearFY2025, Sep 30, 2025FY2025, Dec 31, 2025
Revenue$9M$9M
Revenue growth163.5%28.1%
Revenue growth a year, last 5 years—29.2%
Gross margin56.5%29.5%
Operating margin−46.5%−552.6%
Net margin−39.6%−543.3%
Free cash flow−$3M−$37M
Free cash flow margin−32.1%−409.5%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count50.0%53.4%
Last close$0.67$0.62
P/E at the last close——
Insider trades, last 12 monthsbought $736,999, sold $54,879bought $420,805, sold $126,869
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Neuroone Medical TechnologiesInspireMD
Operating margin
Percent of revenue
Neuroone Medical TechnologiesInspireMD
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Neuroone Medical TechnologiesInspireMD

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Neuroone Medical Technologies and InspireMD pages.